MEDIGENE N (MDG1.SG) (MDG1.SG) stock: key figures, P/E, revenue and dividend
Materials · Diversified Metals & Mining · Germany · ISIN DE000A1X3W00
Price
0.02 EUR
Market cap
112,517.00 EUR
P/E (2023)
–
P/S (2023)
0.02
Dividend yield
0.00 %
Net margin
-268.10 %
Return on equity (ROE)
-76.79 %
Return on assets (ROA)
-51.01 %
MEDIGENE N (MDG1.SG) financials
| Fiscal year | 2022 | 2023 |
|---|---|---|
| Revenue | 31.25 m EUR | 6.03 m EUR |
| Gross profit | 29.26 m EUR | 4.39 m EUR |
| Operating income | -8.73 m EUR | -16.15 m EUR |
| EBIT | -8.72 m EUR | -16.04 m EUR |
| Net income | -8.33 m EUR | -16.18 m EUR |
| Diluted EPS – continuing operations | -0.64 EUR | -1.25 EUR |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About MEDIGENE N (MDG1.SG)
There is no Profile data available for MDG1.SG.
More stocks
- ProPhase Labs, Inc. (PRPH)
- Hongchang International Co., Ltd (HCIL)
- Digital Brands Group, Inc. (DBGI)
- Sigyn Therapeutics, Inc. (SIGY)
- First Choice Healthcare Solutions, Inc. (FCHS)
- Data443 Risk Mitigation, Inc. (ATDS)
- Petros Pharmaceuticals, Inc. (PTPI)
- Winvest Group Ltd (WNLV)
- Kuber Resources Corp (KUBR)
- APPlife Digital Solutions Inc (ALDS)
- Recon Technology, Ltd (RCON)
- Cenntro Inc. (CENN)
Not investment advice. All data without warranty, price as of 30.06.2026. Details in the risk notice.